EchoMD Automated Ejection Fraction Software vs Tempus ECG-AF
AI Verdict
Choose EchoMD Automated Ejection Fraction Software if…
Choose EchoMD Automated Ejection Fraction Software if your primary need is to streamline and standardize the assessment of cardiac function through echocardiography. This tool is ideal for clinics and hospitals seeking to improve the efficiency and consistency of left ventricular ejection fraction (EF) measurements, reducing manual variability and accelerating cardiac evaluations.
View EchoMD Automated Ejection Fraction Software →Choose Tempus ECG-AF if…
Choose Tempus ECG-AF if your objective is to proactively identify older patients at elevated risk of developing new-onset atrial fibrillation within the next year. This solution is best suited for healthcare systems focused on early intervention and risk stratification in patients aged 65 or older, enabling timely follow-up and management strategies to prevent AF-related complications.
View Tempus ECG-AF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoMD Automated Ejection Fraction Software | Tempus ECG-AF |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor |
| Deployment | On-premise (via DICOM PACS integration) | Software solution, integrated into healthcare facility systems with advanced cardiology algorithms. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-AFTempus ECG-AF offers superior usability by integrating seamlessly into existing ECG platforms and EHRs, operating largely in the background without requiring a dedicated user interface or additional steps from clinicians. EchoMD Automated Ejection Fraction Software, while automating aspects of echocardiogram interpretation, still involves processing existing imaging studies, which may require more direct user interaction.
Clinical Value
Tempus ECG-AFWhile EchoMD Automated Ejection Fraction Software improves the accuracy and efficiency of a critical diagnostic measurement (EF), Tempus ECG-AF provides a novel predictive capability. It identifies patients at increased risk of developing new-onset Atrial Fibrillation within 12 months, enabling proactive intervention and potentially preventing serious complications like stroke.
Pricing & Value
Tempus ECG-AFTempus ECG-AF clearly outlines its financial viability by stating that CMS reimbursement is available with specific CPT codes and a Medicare rate, effective January 1, 2025. In contrast, EchoMD Automated Ejection Fraction Software only provides 'contact for pricing,' offering no transparency regarding reimbursement or cost-effectiveness.
Enterprise Readiness
Tempus ECG-AFBoth tools are FDA cleared and HIPAA compliant, indicating foundational readiness. However, Tempus ECG-AF explicitly offers a Business Associate Agreement (BAA) and details compatibility with major ECG machine vendors (GE and Philips) and EHR systems, demonstrating a more comprehensive and transparent approach to enterprise integration and data handling.
Innovation
Tempus ECG-AFEchoMD Automated Ejection Fraction Software innovates by automating and standardizing an existing diagnostic process. Tempus ECG-AF demonstrates greater innovation by being the first FDA-cleared AI algorithm for predicting the risk of new-onset Atrial Fibrillation from standard ECGs, shifting from reactive diagnosis to proactive risk identification.
Support & Docs
Tempus ECG-AFTempus ECG-AF provides clear and multiple channels for customer support, including dedicated email addresses, phone lines, and a documented Service-Level Agreement with specified response times. While Caption Health mentions an email for support and access to a manual for EchoMD, Tempus offers a more comprehensive and transparent support structure.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoMD Automated Ejection Fraction Software | Tempus ECG-AF |
|---|---|---|
| Name | EchoMD Automated Ejection Fraction Software | Tempus ECG-AF |
| Company | Bay Labs (now Caption Health) | Tempus AI, Inc. |
| Tagline | AI-powered automated ejection fraction calculation for echocardiograms. | Advancing precision medicine through the practical application of artificial intelligence in healthcare. |
| Description | EchoMD Automated Ejection Fraction Software by Bay Labs (now Caption Health) uses AI to automatically select optimal echocardiogram clips and calculate left ventricular ejection fraction (EF), improving efficiency and accuracy in cardiac evaluation. | Tempus ECG-AF is an FDA-cleared AI-based algorithm that analyzes 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter (AF) within the next 12 months, supporting earlier identification and follow-up. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
| Specialties | Cardiology, Critical Care, Emergency Medicine, Radiology | Cardiology, Geriatrics, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring EchoMD Automated Ejection Fraction Software and Tempus ECG-AF.
Frequently Asked Questions
More Comparisons
More matchups featuring EchoMD Automated Ejection Fraction Software or Tempus ECG-AF
Backers
Who funded each tool's parent company.